Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9048464 | 0.85 | PTGIR (0.42) | PTGIRCA1CA2ACHESIGMAR1 | |
| SCHEMBL9047483 | 0.78 | ACHE (0.40) | PTGIRCA1CA2ACHESIGMAR1 | |
| SCHEMBL9427081 | 0.77 | PTGIR (0.43) | PTGIRSIGMAR1 | |
| SCHEMBL9427080 | 0.77 | PTGIR (0.39) | PTGIRACHEDRD4 | |
| SCHEMBL9427328 | 0.77 | SIGMAR1 (0.44) | PTGIRACHESIGMAR1 | |
| SCHEMBL9427497 | 0.74 | PTGIR (0.48) | PTGIRSIGMAR1 | |
| SCHEMBL9048016 | 0.73 | PTGIR (0.48) | PTGIRSIGMAR1 | |
| SCHEMBL9047496 | 0.73 | TAS1R3 (0.40) | PTGIRCA1CA2ACHEDRD4 | |
| SCHEMBL9047991 | 0.72 | PTGIR (0.38) | PTGIRCA1CA2ACHESIGMAR1 | |
| SCHEMBL9048933 | 0.72 | PTGIR (0.52) | PTGIRACHEDRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0542203-B1 | Fused benzeneoxyacetic acid derivatives as PGl2 receptor agonists | ONO PHARMACEUTICAL CO (JP) | 1996-07-03 | — | — | EP | claimed |